NovoCure Limited 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Allyson Ocean

NovoCure Limited’s own tally for this item (“Elect Director: Allyson Ocean”): 81,178,295 for, 1,666,945 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,280,558 for, 4 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Asaf Danziger

NovoCure Limited’s own tally for this item (“Elect Director: Asaf Danziger”): 81,489,609 for, 1,388,512 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,164,405 for, 116,157 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: David Hung

NovoCure Limited’s own tally for this item (“Elect Director: David Hung”): 80,768,325 for, 2,039,529 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,164,404 for, 116,158 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Frank Leonard

NovoCure Limited’s own tally for this item (“Elect Director: Frank Leonard”): 82,547,254 for, 356,494 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,280,561 for, 1 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Jeryl Hilleman

NovoCure Limited’s own tally for this item (“Elect Director: Jeryl Hilleman”): 81,547,820 for, 1,293,373 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,164,405 for, 116,157 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Kinyip Gabriel Leung

NovoCure Limited’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 79,455,754 for, 3,370,420 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,117,145 for, 163,417 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Kristin Stafford

NovoCure Limited’s own tally for this item (“Elect Director: Kristin Stafford”): 81,584,398 for, 1,272,045 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,280,559 for, 3 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Martin Madden

NovoCure Limited’s own tally for this item (“Elect Director: Martin Madden”): 81,360,641 for, 1,461,539 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,280,559 for, 3 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: Timothy Scannell

NovoCure Limited’s own tally for this item (“Elect Director: Timothy Scannell”): 81,540,531 for, 1,292,301 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,164,405 for, 116,157 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: William Doyle

NovoCure Limited’s own tally for this item (“Elect Director: William Doyle”): 80,241,009 for, 2,664,190 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,125,635 for, 154,927 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: Election of Directors: William Vernon

NovoCure Limited’s own tally for this item (“Elect Director: William Vernon”): 81,349,410 for, 1,483,356 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 33,164,405 for, 116,157 against, 18,379 abstained.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Description as filed by funds: THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.

NovoCure Limited’s own tally for this item (“4. Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan”): 41,680,622 for, 41,161,139 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the Company's Amended and Restated 2024 Omnibus Incentive Plan was approved as an ordinary resolution based upon the following votes:”
Support: 50.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 13,495,550 for, 19,929,950 against, 18,379 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: A non-binding advisory vote to approve executive compensation.

NovoCure Limited’s own tally for this item (“3. Approval of a non-binding advisory vote to approve executive compensation”): 75,392,168 for, 7,422,876 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve executive compensation on a non-binding advisory basis was approved as an ordinary resolution based upon the following votes:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of NovoCure Limited’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 57 managers: 32,426,128 for, 817,433 against, 18,379 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 212 managers: 50,723,501 for, 4,671,464 against, 12 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: THE APPROVAL AND RATIFICATION OF THE APPOINTMENT, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS THE AUDITOR AND INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE COMPANY'S FISCAL YEAR ENDING DECEMBER 31, 2026.

NovoCure Limited’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 91,436,910 for, 2,337,255 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve and ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 33,097,443 for, 146,119 against, 18,379 abstained.

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.